Award
Delivery Order #SPE2DR26FG5BN
Delivery Order for KISQALI Pharmaceutical Supply to Federal Healthcare Programs
Buyer
Defense Logistics Agency
Award Amount
$4,916.62
Ceiling
$4,916.62
Awarded
February 26, 2026
Period of Performance
Feb 26, 2026 – Mar 19, 2026
Identifier
SPE2DR26FG5BN
NAICS
424210
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a leading distributor in the pharmaceutical sector, as part of its existing indefinite delivery vehicle (IDV) contract focused on pharmaceutical supply services. The contract entails procuring a specific pharmaceutical product, KISQALI 200 mg, for daily use, supporting federal health program needs. The delivery order reflects a targeted acquisition to fulfill immediate medication requirements within a short-term timeframe. The award underscores the federal agency’s commitment to maintaining uninterrupted access to critical pharmaceuticals, contributing to consistent healthcare service delivery. The scope of work includes the provision and timely delivery of the specified drug dosage at the designated location in Conshohocken, PA. This task order was issued under a competitive IDV contract framework, capitalizing on previously established procurement vehicles to ensure efficient acquisition. The contract period covers a brief window in early 2026, aligning with the agency’s operational scheduling for pharmaceutical distribution. This delivery order complements the broader long-term pharmaceutical supply contract in place, emphasizing ongoing pharmaceutical management and support.
Description
4570971201!KISQALI 200 MG DAILY DOSE UU 21S